NeoGenomics, Inc. Revenue
NeoGenomics, Inc. (NEO) reported Revenue of $67.75 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-06.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-08-06
- NeoGenomics, Inc. revenues for the quarter ending 2018-06-30 was $67.75M, a 8.80% increase year-over-year.
- NeoGenomics, Inc. revenues for the quarter ending 2018-03-31 was $63.42M, a 10.44% increase year-over-year.
- NeoGenomics, Inc. revenues for the quarter ending 2017-06-30 was $62.26M.
- NeoGenomics, Inc. revenues for the quarter ending 2017-03-31 was $57.43M.
| Period end | Revenues 3 month | Revenues 6 month |
|---|---|---|
| 2018-06-30 | $67.75M 10-Q · filed 2018-08-06 | $131.17M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $63.42M 10-Q · filed 2018-05-08 | |
| 2017-06-30 | $62.26M 10-Q · filed 2018-08-06 | $119.69M 10-Q · filed 2018-08-06 |
| 2017-03-31 | $57.43M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |